Hematopoietic progenitor cells of the AIJ strain of mice show a pronounced defect in the ability t o form colonies or proliferate in response t o interleukin-3 (IL-3). Comparison of immunoblots of AIJ mast cells and of mast cells from the C57BL16 strain that respond normally t o IL-3 showed that, in both strains, a 125-kD band of the expected size was recognized by an antibody against the p chain of the IL-3 receptor, the AlC2A molecule. However, in the C57BLl6 cells, there was an additional 110-kD species not seen in cells of the AIJ strain. Analyses using bone marrow-derived mast cells from a panel of AIJ x C57BLl6 and AIJ x C57BLl6 recombinant inbred (RI) mice showed that the hypo-responsiveness t o IL-3 is governed by a single gene. However, the absence of this 110-kD species in the A/J strain did not co-map with IL-3 hypo-responsiveness but did indeed map t o the AlC2A genetic locus. These data show that this trait in the AIJ strain was due t o a polymorphism of the AIC2A gene unrelated t o IL-3 hypo-responsiveness. Typing of the RI strains for the markers D14Mit98, D14Mit14, and D14Mit133 mapped the locus determining hypo-responsiveness t o IL-3 NTERLEUKIN-3 (IL-3) is produced by immunologically I activated T lymphocytes and mast cells and appears to be a major factor in the T-lymphocyte-dependent mastocytosis associated with some parasitic infections. IL-3 stimulates the survival and proliferation of pluripotential hematopoietic stem cells and the progenitor cells of all hemopoietic lineages, with the possible exception of those of T lymphocytes. IL-3 also regulates the survival and function of mature cells of certain lineages, such as mast cells, basophils, eosinophils. megakaryocytes, and macrophages.' The cell surface receptor for 1L-3 is composed of at least two chains, a specific a chain and a common p (,&) chain.' In humans, the pc molecule is also a component of the receptors for IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF) in which it interacts with one of three specific a subunits, each of which binds specifically to either IL-3, IL-5, or GM-CSF.' In the mouse, the , 6 chain of the IL-3 receptor can be provided by either the AIC2B molecule, which, like the , Oc molecule in the human system, is shared with the IL-5 and GM-CSF receptors, or by a product of a duplicated gene, 
t o the subtelomeric region of chromosome 14, the region that also bears the gene encoding the a chain of the IL-3 receptor (IL-3Ra). Immunofluorescence analyses indicated that IL-3Ra protein was undetectable on fresh bone marrow cells from AIJ mice, although clearly detectable on cells from the responder C57BLl6 strain. However, IL-3Ra was readily detectable at normal levels on AIJ mast cells generated by culture of AIJ bone marrow cells in a combination of IL-3 and steel factor. Moreover, IL-3Ra on these A/J mast cells appears t o be functional in that IL-3 stimulation of these cells results in tyrosine phosphorylation events characteristic of IL-3 signaling, including tyrosine phosphorylation of the p chain of the IL-3 receptor, Jak-2 kinase, and SHPTP2. Collectively, these data indicate that the hypo-responsiveness of A/J mice t o IL-3 is due t o a defect in the gene encoding IL-3Ra and that, although this defect gives rise t o reduced expression of a chain on primary bone marrow cells, this defect is not absolute and that, under certain circumstances, AIJ cells can express functional receptors. 0 1996 b y The American Society of Hematology.
the highly homologous AIC2A protein.' AIC2A itself binds IL-3 with low affinity and, unlike AIC2B, interacts only with the a chain of the IL-3 receptor (IL-3Ra) and not that of the GM-CSF or IL-5 receptors. Both IL-3Ra and one of the two p chains must be expressed on the same cell to form a functional, high-affinity IL-3 receptor, and the cytoplasmic domains of both the cy and p chains are needed for generation of the intracellular signals required for mitogenesis' (Orban et al, unpublished observations).
Several inbred strains of mice have been reported to be hyporesponsive to IL-3."' Hematopoietic progenitor cells of the A/J, AKR, A.TH, and A.TL strains of mice are defective in their ability to form colonies or proliferate in response to IL-3.'."' FI hybrids between A/J and the responder C57BL/ 6 strain exhibit normal responses to IL-3,4 indicating that the defect is recessive. F1 hybrids between AKR and A/J mice fail to respond to IL-3, indicating that these nonresponder strains share defects in a common gene. Although A/J bone marrow cells respond poorly to 1L-3 alone, they exhibit a synergistic response to a combination of IL-3 and CSF-1: ' indicating that responses to IL-3 are not totally absent.
Using recombinant inbred (RI) mice, we have shown that the hypo-responsiveness of A/J cells to IL-3 fails to map to the , B chain locus and fails to correlate with a polymorphism in the AlC2A chain of the IL-3 receptor, but instead maps with 100% concordance to the subtelomeric region of chromosome 14 that bears the gene encoding IL-3Rn and correlates with the defective expression of a chain protein on the surface of fresh bone marrow cells. These data are consistent with the report of Ichihara et alH that there is a 5-bp deletion in intron 7 of the gene that encodes IL-3Rn in A/J mice and in other IL-3 hypo-responsive strains' and that this results in the expression of a defective a chain protein that does not appear at the cell surface. However, we show that a certain population of A/J-derived hematopoietic cells, bone marrow-derived mast cells, can express normal levels of functional IL-3Ra at the cell surface. Moreover, this IL-3Ra For personal use only. on October 23, 2017. by guest www.bloodjournal.org From appeared to be functional in that IL-3 stimulation of these cells results in tyrosine phosphorylation events characteristic of IL-3 signaling, including tyrosine phosphorylation of the , B chain of the IL-3 receptor, Jak-2 kinase, and SHPTP2. These results indicate that the hypo-responsiveness of A/J mice to IL-3 results from a defect in the expression of IL3Ra but that this defect is not absolute and that, under certain circumstances, A/J cells can express functional receptors.
MATERIALS AND METHODS
Animals and preparation of fresh cells. All mouse strains were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice were killed by cervical dislocation or C 0 2 anesthesia, bone marrow cells were flushed from the femurs using HEPES-buffered Hanks solution, and red blood cells were removed by hypotonic lysis.
Cell culture. Bone marrow cells were cultured at 106/mL in humidified incubators at 37"C, 5% CO, (vol/vol) in RPMI 1640 medium (GIBCO BRL, Grand Island, NY) supplemented with 10% (voVvol) fetal bovine serum (GIBCO BRL), 20 pmol/L 2-mercaptoethanol, 100 U/mL penicillidstreptomycin, and 2 m m o m L-glutamine. Cytokines added to cultures included chemically synthesized murine IL-3 (1 pg/mL; courtesy of Dr Clark-Lewis, The Biomedical Research Centre (Vancouver, Canada), synthesized with cysteineto-alanine substitutions at positions 79 and 140 to facilitate folding of the mature IL-3 protein) and, where indicated, recombinant murine Steel locus factor (SLF; 500 ng/mL). For the typing of RI strains, bone marrow cells were cultured in JL-3 alone for 3 weeks with cultures split weekly. Total cells were then counted and the percentage of mast cells determined by staining with Toluidine Blue and Astra Blue.
Nucleated bone marrow cells were placed in triplicate I-mL cultures at 2.5 to 5 X IO4 cells/mL in cell culture medium supplemented with 0.3% agar, selected fetal calf serum (20%), and growth factors as indicated (Fig lA, 1 pg/mL synthetic murine IL-3,500 ng/mL recombinant murine SLF; Fig IB, 1 pglmL synthetic murine IL-3, 1 pg/mL factor "mix" consisting of synthetic murine JL-3, 500 ng/mL recombinant murine SLF, 1 .O U/mL recombinant GM-CSF, 5% of a 10-fold concentrated medium conditioned by L-cells as a source of CSF-I). Colonies were defined as collections of 40 cells or greater and were counted on day 7.
Assays were performed according to the method described by Schrader and Crapper." Briefly, nine aliquots of 3,000 A/J or C57BW6 mast cells (thrice washed with RPMI 1640) were added to the wells of Terasaki trays (Lux Corp, Newbury Park, CA) in 15 pL of culture medium containing synthetic murine IL-3 (2 pg/mL) or recombinant murine SLF (500 ng/mL) or no growth factor. Trays were incubated at 37°C for 2 hours, pulsed for 18 hours with [3H]-thymidine, and harvested onto glass fiber filters. Filters were washed then counted in a liquid scintillation counter.
Genetic mapping was performed using the RI Manager program, version 2.3 (Kenneth F. Manly, Rosewell Park Cancer Institute, Buffalo, NY), with linkage evaluation performed as described by Silver." Mapping information on the AxB and BxA sets of RI mice was largely from published data.'* However, Dr N. Gough (The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia) generously provided unpublished data on the mapping of the gene encoding IL-3Ra obtained using a recombinant inbred panel of C57BU6 x DBAl mice. A strain distribution map ofthe loci D14Mit98, D14Mit14, and D14Mit133 (loci found in the subtelomeric region of chromosome 14) for the RI strains in these panels was constructed with data from polymerase chain reaction (PCR) amplification of genomic DNA, based on information on these loci provided on-line by The Whitehead InstituteMIT Genome Bone marrow colony assays.
Thymidine incorporation assays.

Genetic mapping.
Center with ice-cold FACS buffer, held at 4°C for 3 minuterwith fluorescein isothiocyanate (F1TC)-labeled secondary antibody, washed once with ice-cold FACS buffer, and then resuspended on ice in FACS buffer. The primary antibody consisted of the F(ab'), fragments of an affinity-purified, rabbit antiserum against a synthetic peptide corresponding to residues Serl7 to Asp67 of the mature IL-3Ra. The peptide incorporated a Cterminal addition of GlyGlyCys to facilitate coupling and was kindly synthesized by Dr Ian Clark-Lewis (The Biomedical Research Centre, Vancouver, British Columbia, Canada). For affinity purification of antipeptide antibodies, this peptide was coupled to Sepharose." F(ab'), fragments were produced by pepsin cleavage of the affinitypurified antiserum.I3 The secondary antibody was a FITC-labeled goat antirabbit IgG (H&L) F(ab'), reagent (Sigma, St Louis, MO) used at 1.1 pg/ml. Analysis of the specificity of primary antibody binding was performed by determining the effect of addition of 500 pg/mL of the synthetic IL-3Ra peptide (Serl7 to Asp67) to diluted antibodies at 4°C for 5 minutes before the addition of the antibody mix to the washed target cells. Labeled cells were analyzed by flow cytometry on a FACScan cell analyzer (Becton Dickinson, San Jose, CA).
Stimulation of cells with the synthetic IL-3 was performed as previously des~ribed.'~,'' Briefly, cells were deprived of growth factor (SLF and IL-3) by culture for 18 hours in media in which the levels of SLF and IL-3 had been reduced 10-fold, washed three times, and then stimulated with IL-3 at 10 pg/mL for 10 minutes, conditions previously determined to induce maximal levels of tyrosine pho~phorylation.'~~'~ Cells were washed and cell pellets were lysed in immunoprecipitation buffer (IP buffer: 50 mmol/L TrisHC1, pH 7.5; 10% (vol/vol) glycerol; 1 % (voVvol) NP-40, 150 mmol/L NaC1; 5 mmoVL EDTA; 1 mmoVL sodium orthovanadate; 1 mmol/L sodium molybdate; I O mmoVL sodium fluoride; 40 pg/mL PMSF; 10 pg/mL aprotinin; 10 pg/mL soyabean trypsin inhibitor; 10 pg/mL leupeptin; 0.7 pg/mL pepstatin) as previously de~cribed.'~ Nuclei and intact cells were removed by centrifugation for 1 minute at 4°C in a microfuge at full speed.
Sodium dodecyl sugaie-polyacrylamide gel electrophoresis (SDS-
) and immunoblotting. SDS-PAGE and immunoblotting were performed as previously de~cribed.'~ The affinity-purified, rabbit anti-AIC2A antiserum was raised and purified using a synthetic peptide corresponding to the N-terminal 74 residues of the mature murine AIC2A p chain, as described previou~ly,'~ and was used at 0.5 pg/mL for immunoblotting. Goat antirabbit horse radish peroxidase-conjugated antibody (Dako, Dimension Laboratories, Mississauga, Ontario, Canada) was used at a concentration of 0.05 pg/mL. Immunoblots were developed using the ECL system (Amersham, Arlington Heights, IL). Kodak X-AR 5 film (Eastman Kodak, Rochester, NY) was used for detection of ECL signals.
TAAATACTCACTCTGTGGTGAGG3' and S'CTCCATGAA-
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Cell stimulation and preparation of lysates.
RESULTS
Using colony assays, we confirmed the reports of oththat A/J bone marrow cells were hypo-responsive to ers4.6.7
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From -IL-3 but responded normally to other hemopoietic growth factors such as CSF-1 or GM-CSF (data not shown). We also confirmed that A/J cells responded synergistically to a mixture of IL-3 and CSF-1 with the generation of macrophage colonies. Moreover, in experiments with certain batches of fetal calf serum (FCS), we observed small numbers of clusters (<40 cells) growing in response to high concentrations of IL-3 alone, perhaps reflecting synergistic interactions of IL-3 and certain factors in FCS. We extended the previous observations of synergistic responses of A/J bone marrow cells to combinations of IL-3 and other factors by showing a dramatic synergy of IL-3 and SLF, either factor alone having no significant colony-stimulating activity (Fig  1 A) .
Similar results were obtained in liquid cultures. Whereas liquid cultures of C57BU6 bone marrow cells stimulated with IL-3 alone proliferated vigorously and, after 3 weeks, generated homogeneous populations of mast cells, A/J bone marrow cells generated significantly fewer cells and only a small percentage of these were mast cells. However, experiments in which bone marrow cells were stimulated with a mixture of IL-3 and SLF gave strikingly different results. Thus, in the presence of IL-3 and SLF, A/J bone marrow cells proliferated as vigorously as the C57BL/6 bone marrow cells, with a 50-to 100-fold increase in total cell count over an 8-day culture period. Cells from cultures of both A/J and C57BU6 bone marrow cells had the histochemical characteristics of mast cells with prominent cytoplasmic granules staining with toluidine blue or astra blue (data not shown). Analysis of hypo-responsiveness to IL-3 using a panel of recombinant inbred mice. The availability of a panel of RI mice in which one parental strain was A/J (hypo-responsive to IL-3) and the other C57BU6 (responsive to IL-3) offered an opportunity to determine whether IL-3 hypo-responsiveness of A/J mice was controlled by a single gene and the possibility of mapping this locus. Panels of strains of A/ J x C57BL/6 (AxB) and C57BU6 X A/J (BxA) RI mice'* were typed by analysis of the ability of bone marrow progenitor cells to respond to IL-3 with colony formation in agarcolony assays (Fig 1B) and for their capacity to generate mast cells in a 3-week liquid culture in the presence of IL-3 alone. The results of these two assays were concordant. The absence of an intermediate phenotype in the strain distribution pattern suggested that the trait was controlled by a single IOCUS.'~ A polymorphism of the 0 chain of the IL-3 receptor in A/ J mice. Immunoblots of extracts from cells of C57BU6 origin that were analyzed with affinity-purified antibodies to the N-terminus of AIC2A showed two major bands, one corresponding to a molecular weight of about 125 kD and a second of only 110 kD (Fig 2) . The 125-kD protein corresponded to the expected electrophoretic mobility of the AIC2A 0 chain of the IL-3 receptor, as identified in crosslinking studies with radiolabeled IL-3." Moreover, this 125-kD protein was rapidly tyrosine phosphorylated after stimulation with IL-3, with a consequent retardation of electrophoretic m0bi1ity.I~ In contrast, the lower 1 10-kD band did not correspond to any species identified in cross-linking experiments and was not phosphorylated on tyrosine in response to IL-3. Interestingly, unlike the 125-kD species, the 1 IO-kD species is not bound by a concanavalin-A Sepharose column, suggesting that the two species are glycosylated differently (Duronio et al, data not shown). Mast cells were generated from hyporesponder A/J and responder CS7BL/6 (BL/6) mice by culturing bone marrow cells with IL-3 and SLF, and immunoblots were prepared of whole-cell lysates from these cells using the anti-0 chain antibody. The expected 125-kD AIC2A protein could be detected in both CS7BL/6 and A/J samples. In the A/J samples, the larger 125-kD species migrated slightly faster than the corresponding band in the CS7BL/6 samples and could be resolved as a doublet when separated on a larger gel. However, the additional I IO-kD band that was observed in the CS7BL/6 responder mice was entirely absent in cells from the A/J hyporesponder mice (Fig 2) .
IL-3 h?po-responsiveness does not co-map with the 0 chain polvmorphism. To determine whether the absence of the 110-kD form of AIC2A correlated with hypo-responsiveness to IL-3, mast cells were generated from fourteen strains of the RI mice by culture of bone marrow cells in IL-3 and SLF and analyzed by immunoblotting. As summarized in Table I , there was a clear discordance between inheritance of the A/J-type absence of the 1 IO-kD isoform of AIC2A and hypo-responsiveness to IL-3. Genetic mapping analyses indicated that the absence of the 1 IO-kD band mapped tightly to a region on chromosome IS close to c-sis (Table 1 and Fig 2) , the region subsequently reported to contain the AIC2A gene locus." Collectively these data indicate that the presence of the I IO-kD form of AIC2A is determined by a polymorphism of the gene encoding AIC2A. However, the distinct strain distribution patterns of IL-3 hypo-responsiveness and the polymorphism in the IL-3 receptor 0 chain (Table 1 ) indicate that the AIC2A locus was not linked to the trait of IL-3 hyporesponsiveness.
IL-3 h~poresponsivettess maps to the locus containing the IL-3Ra gene. The chromosomal localization of the gene encoding IL-3Ra was mapped by Dr N. Gough to the subtelomeric region of chromosome 14 using a different panel of RI mice (personal communication) and subsequently by Miyajima et d.'* There was a lack of information for the AxB and BxA R1 panels on the strain distribution patterns of loci in this region of chromosome 14. Thus, to test the hypothesis that the hypo-responsiveness of A/J mice to IL-3 maps to the gene for IL-3Ra, it was necessary to type the AxB and BxA RI mice for the D14Mit98, D14Mitl4, and D14Mit133 loci, loci known to reside in the subtelomeric region of chromosome 14 and known to exhibit polymorphic differences between A/J and CS7BW6 strains.
PCR amplification of genomic DNA from RI mice was performed using primer pairs specific for each of the markers. These analyses showed tight concordance between the most telomeric of these markers, D14Mit98, and the trait of IL-3 hypo-responsiveness (P < .OOOS; Table 2 ). Thus, like the gene encoding IL-3Ra. the hypo-responsiveness of A/J mice to IL-3 mapped to the subtelomeric region of chromosome 14. These mapping experiments showed that the IL-3 hyporesponsiveness of the A/J strain was due to a defect in a single gene and that the defective gene was either that encoding IL-3Ra or a gene closely linked to the IL-3Ra locus.
IL-3 receptor a chain cannot he detected on fresh A/J hone marrow cells. Our genetic studies showing tight linkage of the trait of hypo-responsiveness to IL-3 and the locus bearing the IL-3Ra gene suggested that the hypo-responsiveness to 1L-3 was due to a defect in the IL-3Ra. To test this hypothesis, we investigated whether there were abnormalities in the expression of the IL-3Ra protein in A/J mice. Fresh bone marrow cells from CS7BL/6 or A/J mice were examined by flow cytometry using F(ab')2 fragments of an affinity-purified polyclonal antibody specific for the a chain of the IL-3 receptor. In control experiments, these anti-IL-3Ra anti- Locus  AB1  AB4  AB5  AB6  AB11  AB13  AB14  AB15  AB19  AB20  AB23  AB24  EA7  EA8   IL-3 For 
Bone marrow cells from recombinant inbred mice were typed for their responsiveness to IL-3 (locus IL-3 resp.). Phenotypes (PCR polymorphisms) were determined for the loci D14Mit98, D14Mit14, and D14Mit133. Published phenotypes are given for the loci Np-2,12 Tcra,'2 and Xmv- bodies were shown to bind to CTLL cells transfected with the murine IL-3Ra, but not to nontransfected CTLL cells. Moreover, this binding could be specifically inhibited using the synthetic peptide corresponding to residues 17-67 of IL3Ra against which the antibody was raised, but not by a control peptide (Orban et al, unpublished observations). Flow cytometry showed that a small but significant proportion of the fresh C57BL/6 bone marrow cells were clearly recognized by the anti-IL-3Ra antibody and this staining could be specifically inhibited by competition with the IL3Ra peptide (Fig 3A) . In marked contrast, there was only a low amount of binding of the anti-IL-3Ra antibodies to the A/J marrow cells, and this binding was not significantly reduced in the presence of competing peptide ( P > .05; Fig   3B) . This low or nonspecific binding of the anti-IL-3Ra antibodies to A/J bone marrow cells was a consistent finding in multiple, independent experiments. Together with the genetic studies that show a tight linkage of the IL-3Ra locus and the trait of IL-3 hypo-responsiveness, these findings indicate that the hypo-responsiveness to IL-3 of A/J mice is due to defective expression of the a chain of the IL-3 receptor.
IL-3 can induce tyrosine phosphorylation in A/J bone marrow-derived mast cells. Despite this apparent absence of IL-3Ra protein on fresh bone marrow cells from A/J mice (Fig 3B) , we (Fig 1) and other^^,'.^ have shown that A/J bone marrow cells are capable of responding to IL-3 when assayed by colony formation in the presence of such synergistic growth factors as CSF-1 or SLF. We therefore examined whether mast cells generated by culture of A/J bone marrow for 14 days with IL-3 and SLF were able to respond to IL-3 with the same pattern of intracellular responses as do mast cells from C57BL/6 mice. Stimulation of A/J mast cells with IL-3 produced a pattern of tyrosine phosphorylation on membrane and cytosolic proteins identical to that seen with C57BL/6 mast cells (Fig 4A) . In particular, stimulation with IL-3 resulted in tyrosine phosphorylation of the 135-to 145-kD p chain of the IL-3 receptor (Fig 4A) and of the 120-kD protein tyrosine kinase Jak2 (Fig 4B) . Also visible ( Fig  4A) are other bands characteristically phosphorylated on tyrosine in response to IL-3, namely a 70-kD band that we have previously shown is the tyrosine phosphatase SHPTP2,'4 a 55-kD band that we have shown is Shc" and an uncharacterized 90-kD band.I5 However, although the pattern of tyrosine phosphorylation in A/J mast cells stimulated with IL-3 was qualitatively identical to that seen in C57BL/6 mast cells, the levels of tyrosine phosphorylation were significantly and reproducibly lower. For example, the level of phosphorylation of Jak2 was several-fold lower in IL-3-simulated A/J mast cells than in C57BL/6 mast cells (Fig 4B) . Consistent with these findings of qualitatively normal IL-3 receptormediated signal transduction and tyrosine phosphorylation, PCR-cloning and sequencing of a cDNA fragment encoding the trans-membrane region and cytoplasmic tail of A/J IL3Ra showed that the A/J-derived cDNA sequence was identical to the C57BL/6-derived cDNA sequence (data not shown).
We then tested whether IL-3, in addition to inducing tyrosine phosphorylation, was also capable of delivering a mitogenic signal to A/J bone marrow-derived cells. A/J and C57BL/6 bone marrow cells were cultured in SLF and IL-3 for 7 days, after which they were washed extensively, exposed to medium alone or IL-3 or SLF for 2 hours, and then pulsed for 18 hours with [3H]-thymidine in the presence of the respective cytokine. IL-3 stimulated both A/J and C57BL/6 cells to incorporate comparable amounts of ['HIthymidine over the 18-hour incubation period (Fig 5) . These results suggest that, in these specific culture conditions, IL-3 is capable of delivering a mitogenic signal to both A/J and C57BL/6 cells. However, unlike the C57BL/6 cells, A/J cells were incapable of sustained survival and proliferation in the presence of IL-3 alone. Thus, parallel experiments in which the ['HI-thymidine pulse was delayed showed that, after 3 days of culture in IL-3 alone, A/J cells were dead and incapable of incorporating [3H]-thymidine (data not shown).
IL-3 receptor a chain can be detected on A/J bone marrow-derived mast cells. Although we were unable to detect IL-3Ra on fresh A/J bone marrow cells (Fig 3B) , we hypothesized that the transient responsiveness of A/J cells derived by culture in the presence of SLF and IL-3 might reflect a higher level of the surface expression of IL-3Ra. To address this hypothesis, nucleated bone marrow cells from C57BU 6 and A/J mice were cultured in the presence of SLF and IL-3 for 7 days, starved of IL-3 by culture in SLF alone for 2 days, and then examined by flow cytometric analysis for cell surface expression of IL-3Ra. IL-3Ra could readily be detected on a significant proportion of cells from cultures generated from both C57BU6 (Fig 3C) and A/J (Fig 3D) bone marrow. However, if after culture for 7 days in SLF and IL-3 the C57BU6 and A/J bone marrow-derived cells were maintained in IL-3 alone for 2 days instead of in SLF alone, although the level of IL-3Ra expressed on the surface of C57BU6 cells was considerably reduced (Fig 3E) , we were unable to detect any IL-3Ra protein on the surface of A/J cells (Fig 3F) .
Cultures of C57BU6-or A/J-cell-derived bone marrow cells supplemented with both SLF and IL-3 for 7 days generated similar numbers of IL-3Ra-positive cells (1 I % to 40% in 4 independent experiments) and the levels of IL-3Ra expressed on positive cells and the proportion of IL-3Ra-positive cells were comparable. Similar findings were obtained when day 14 cultured bone marrow cells were analyzed, although the proportion of IL-3Ra-positive cells in each culture had increased somewhat. Histochemical staining of these cultured cells from C57BL/6 and A/J bone marrow confirmed that the medium-sized cells that by flow cytometry stained with the IL-3Ra-specific antibodies contained astra blue and toluidine blue-positive granules, identifying them as immature bone marrow-derived mast cells. Thus, whereas IL-3Ra cannot be detected on fresh A/ J bone marrow cells, it can readily be detected on immature mast cells generated in vitro in the presence of IL-3 and SLF.
A number of genetic defects result in impaired or altered signaling from cell surface receptors in response to soluble or membrane-bound cytokines. For example, achondroplasia is due to a mutation in a receptor for fibroblast growth factor,2" some forms of human X-linked severe combined immunodeficiency result from defects in one chain of the receptor for IL-2,2' and mutations in c-kit, the receptor for steel factor, result in anemia and defects in germ cells, skin, and brain in mice2* and in the skin in humans." We confirmed that the defect in IL-3 responsiveness in A/J mice is not absolute, providing further evidence that IL-3 can synergize with growth factors other than CSF-I by showing a synergy between IL-3 and SLF on A/J cells. We have shown here that the defective response to IL-3 of hematopoietic progenitor cells from NJ bone marrow cells fails to map to the , B chain of the IL-3 receptor or to correlate with a newly described polymorphism in AIC2A, but maps with 100% concordance to the subtelomeric region of chromosome 14 that bears the gene for the a chain of the IL-3 receptor. Moreover, cytofluorometric data showed that there was defective expression of the IL-3Ra protein on fresh NJ bone marrow cells.
Since the submission of our manuscript, Ichihara et al'
For aberrant splicing results in the expression of a defective IL3Ra protein that does not appear at the cell surface, providing an explanation for the lack of responsiveness of A/J cells to IL-3. However, using the AxB and BxA recombinant inbred panels of mice, Ichihara et alx were unable to show a significant linkage between the trait of IL-3 hyporesponsiveness and their most proximal chromosome 14 polymorphic marker, D 14Mi t 14. They thus reasoned that recombination events must have occurred in the strains that show different strain distribution pattems (SDP) between IL-3 hypo-responsiveness and D 14Mit 14 genotype. By characterizing the SDP of a more proximal polymorphic marker on chromosome 14, D14Mit98. we showed that indeed the A/ J hypo-responsiveness to IL-3 maps with 100% concordance to the subtelomeric region of chromosome 14.
However, in contrast to the findings of Ichihara et al, ' we found that IL-3Ra protein could be detected in significant levels on the surface of a subpopulation of primary A/J hematopoietic cells identified as immature mast cells. Our demonstration that A/J bone marrow-derived mast cells can express normal levels of IL-3Ra at the cell surface suggests that there may be tissue or cell-specific variation in the cellsurface expression of IL-3Ra in A/J mice and therefore variation in the apparent phenotype of IL-3 hypo-responsiveness. Short-term (4-hour or 24-hour) incubations of fresh A/J or CS7BL/6 bone marrow cells in SLF and IL-3 had no effect on surface expression of IL-3Ra (unpublished observations), confirming the earlier findings of Sato et al. " The expression of IL-3Ra on a subpopulation of A/J cells generated in a 7-day culture of bone marrow cells with IL-3 and SLF most likely resulted from the generation of a cell population in which cell-surface IL-3Ra was expressed at levels comparaFor personal use only. on October 23, 2017. by guest www.bloodjournal.org From ble with those on a parallel population in cultures of C57BL/ 6 cells. These cells are likely to be mast cells or their progenitors as the frequency of IL-3Ra-positive cells correlated with the frequency of toluidine blue/astra blue-positive mast cells. The enhanced expression of cell-surface IL-3Ra on A/J bone marrow-derived mast cells generated in the presence of IL-3 and SLF was not shared by A/J serosal mast cells in vivo. Thus, we were unable to detect surface expression of IL-3Ra protein on peritoneal mast cells (and macrophages) derived from A/J mice using flow cytometry (unpublished observations). We showed that IL-3Ra expressed on these cultured A/J bone marrow-derived cells was functional with respect to (1) the induction of phosphorylation on tyrosine on a characteristic set of membrane and cytosolic proteins in response to IL-3 (Fig 4A and B) and (2) IL-3-stimulated DNA synthesis (Fig 5) . The IL-3 -stimulated tyrosine phosphorylation events did not represent mere potentiation or prolongation of a response to any residual SLF not removed by washing, because we observed tyrosine phosphorylation on proteins such as the p chain of the IL-3 receptor, the Jak2 kinase,25 and the SHPTP2 phosphatase14 that are known to be phosphorylated in response to IL-3 but not, in these cells, in response to SLF. Although the pattern of phosphorylation on tyrosine on stimulation of A/J cells with IL-3 was qualitatively indistinguishable from that seen in C57BLJ6 cells, the level of phosphorylation of specific substrates (such as Jak2) was reproducibly lower, consistent with our flow cytometric data suggesting that the level of IL-3Ra is in fact lower on these IL-3Ra-positive cultured A/J cells than on similar C57BL/6 cells (Fig 3C and D) .
Although exposure to IL-3 alone clearly stimulated DNA synthesis at 24 hours in A/J bone marrow cells that have been cultures in SLF and IL-3 for 7 days, this response was transient, and at 3 days the cells were dead. It is possible that the observed mitogenic response to IL-3 alone reflected a synergistic effect on cells that had previously received a signal from SLF. Alternatively, the failure of IL-3 to support sustained mitogenesis of the A/J cells might result from the inability of the A/J cells to maintain sufficient levels of functional IL-3Ra on the cell surface when cultured in the presence of IL-3 alone in the absence of SLF. This hypothesis is consistent with our observation that when cells generated from A/J bone marrow by culture in the presence of SLF and IL-3 for 7 days were maintained for a further 2 days in the presence of IL-3 alone, the expression of IL3Ra on the cell surface of these A/J cells decreased to undetectable levels (Fig 3F) . However, when the same cultured cell population was maintained for 2 days in the presence of SLF alone, the expression of IL-3Ra on the A/J cells was maintained at normal levels (Fig 3E) . These data would be consistent with a direct or indirect effect of SLF on the cellsurface expression of IL-3Ra on A/J mast cells, perhaps reflecting regulation of the frequency of the abnormal splicing events detected by Ichihara et a1.' Despite the inability of IL-3 alone to sustain proliferation of A/J cells under these culture conditions, when cell lines were derived from fetal spleen of A/J and C57BL/6 mice using a retroviral vector directing the expression of HOX11, one of two A/J-derived lines exhibited sustained growth in the presence of IL-3 alone, whereas all three of three C57BLJ6-derived lines proliferated in IL-3 alone (unpublished observations). The fact that we were able to derive a cell-line from A/J mice that grew continuously in IL-3 is consistent with the notion that A/J mice can express IL-3Ra that participates in a fully functional IL-3 receptor. Based on the findings of Ichihara et a1,8 it is likely that the IL-3Ra we detected on N J bone marrow-derived mast cells is the product of normally spliced IL-3Ra mRNA and would be predicted to function normally. However, it should be noted that, whereas Ichihara et a18 have shown that the product of the aberrantly spliced IL3Ra gene transcript is not expressed on the cell surface of transfected COS cells or fresh bone marrow, the question remains as to whether it can be expressed on cells such as bone marrow-derived mast cells.
Our findings of decreased expression of IL-3Ra on fresh bone marrow cells appear to conflict with those of an earlier study that showed normal binding of Iz5I-IL-3 to bone marrow cells, as assessed by autoradiography. ' We have shown that the hyporesponsiveness to IL-3 of A/J mice is also evident when IL-3 is administered in vivo (unpublished observations), excluding the possibility that the defect in IL-3 responsiveness and in expression of the a chain of the receptor is restricted to the in vitro situation. However, it is possible that the autoradiographic study measured binding of IL-3 to the AIC2A p chain that can bind IL-3, albeit with low affinity. 26 Our data clearly showed that the defect in A/J mice was unrelated to AIC2A and did not map to the genetic locus bearing the AIC2B gene. However, the difference we detected between the AIC2A molecule from A/J and C57BL/ 6 strains is of some interest. Using specific anti-AIC2A antibodies, we showed that the 110-kD molecule was present in C57BL/6 mast cells but was absent in AIJ cells. Our analyses of recombinant inbred mice not only showed that the absence of this 110-kD molecule was irrelevant to the defective response to IL-3 in A/J mice (Table l) , but also established that this trait mapped to a locus near sis, the region now known to contain the AIC2A gene.I7 These data indicate that the 110-kD species is indeed an alternatively processed form of the AIC2A p chain, resulting from a difference in coding or noncoding sequences of the AIC2A gene in A/J and C57BL/6 mice. The 110-kD species could result from an alternatively spliced AIC2A message, an alternative glycoform of AIC2A, or a cleaved product of the mature AIC2A protein. However, the failure of the 110-kD AIC2A species to undergo tyrosine phosphorylation in response to IL-3 or to be cross-linked to IL-3Ra with 1251-IL-3L5.27 (Duronio et al, unpublished observations) indicates that the 110-kD species probably does not participate in IL-3 signal transduction.
Our data on fresh A/J bone marrow cells agree with the findings of Ichihara et a18 and indicate that the genetic basis of the hyporesponsiveness to IL-3 in A/J mice is a defect in the gene encoding IL-3Ra. However, our finding that the IL-3Ra protein can be expressed at normal levels on bone marrow-derived mast cells and can function suggest that the defect is ultimately a quantitative one. The existence of tissue-specific RNA splicing in cells of the hematopoietic system is well established and is perhaps best exemplified by For personal use only. on October 23, 2017. by guest www.bloodjournal.org From the numerous splice-generated variants of the CD45 molecule found on the surface of certain lineages of hematopoietic cells.** One possible explanation for the difference in the levels of IL-3Ra seen between bone marrow-derived mast cells and the bulk of other hematopoietic cells found in primary bone marrow may relate to tissue-specific or cell lineage-specific splicing of the primary IL-3Ra gene transcript, with a consequent tissue-specific or cell lineage-specific expression of the wild-type or defective forms of the IL-3Ra protein.
